The pursuit of developing oral insulin as a more patient-friendly alternative to injections for diabetic individuals has faced significant challenges due to the body’s natural defense mechanisms. The mucus lining in the gut acts as a selective barrier, allowing nutrients to pass through while blocking potentially harmful substances like insulin. This barrier is a major hurdle in the efficient delivery of oral insulin, as gastrointestinal enzymes quickly degrade the insulin before it can be absorbed.
To overcome this obstacle, researchers are exploring the use of “smart carriers” that can effectively transport drugs across the mucus barrier. Ionic liquids (ILs), which are salts that remain in a liquid state at room temperature, have emerged as promising candidates for enhancing drug delivery. These ILs have the ability to stabilize drugs and improve their penetration through the mucus lining.
A team of researchers from IIT-Guwahati has made significant progress in oral insulin delivery by utilizing an ionic liquid called choline bicarbonate-maleic acid (CBMA) as a smart carrier. The CBMA IL works by promoting the aggregation of mucin, a key component of mucus, and disrupting its normal network structure. This restructuring creates pathways that facilitate the transport of drugs, analogous to enlarging the holes in a net by clumping the wires together.
At a molecular level, the interaction between the choline bicarbonate-maleic acid-based IL and mucin polymer alters the mucus structure, allowing for improved drug delivery. This innovative approach offers insights into the development of oral and site-specific therapeutic drugs, presenting a potential solution for enhancing the delivery of protein-based medications like insulin and therapeutic antibodies in pill form.
In simulated human intestinal conditions, the researchers demonstrated that ILs not only enhance the stability of model protein drugs like bovine serum albumin but also improve their ability to traverse the mucus barrier. This research paves the way for a more effective strategy for oral protein drug delivery, potentially revolutionizing the way patients receive protein-based treatments by offering them in pill form rather than through injections.
Complementing the work at IIT-Guwahati, another group of scientists, primarily from the NSGM Institute of Pharmaceutical Sciences, has shown promising results in prolonging the retention of insulin-loaded chitosan-coated solid lipid nanoparticles. The chitosan coating on these nanoparticles enhances their adhesion to intestinal mucus, thereby increasing the duration the insulin molecules remain at the absorption site and improving their chances of crossing the mucus barrier for systemic uptake.
Key Takeaways:
– Ionic liquids show promise as smart carriers for enhancing drug delivery across the mucus barrier in the quest for oral insulin.
– The innovative use of choline bicarbonate-maleic acid-based IL by IIT-Guwahati researchers demonstrates improved stability and permeability of protein drugs.
– The development of chitosan-coated solid lipid nanoparticles presents an alternative approach to prolonging the retention and absorption of insulin for enhanced oral delivery.
Tags: lipid nanoparticles, drug delivery
Read more on thehindubusinessline.com